Research news

Search news

Browse by category


Select all - Clear all

Can existing drugs be effectively combined to treat COVID-19?

Leading drug developers publish insights in three prestigious international journals.

A team of international researchers including experts from Certara, the

Breakthrough discovery paves the way for preventing sugar-induced liver disease

A team of international researchers including Monash University academics has discovered that, contrary to previous belief, fructose causes liver toxicity by changing the barrier function of the intestine.

New Monash site chronicles contributions of pharmacists during COVID-19

The Monash Faculty of Pharmacy and Pharmaceutical Sciences has launched a new website aimed at capturing the wide variety of contributions that

Monash University to accelerate the development of novel medicine designed to save women’s lives in child birth in collaboration with Janssen

Postpartum haemorrhage (PPH), a condition of excessive blood loss after birth, is the world’s leading cause of maternal mortality, resulting in an estimated 60,000 deaths per year in resource-limited countries. A novel form of oxytocin, an

MIPS researchers PIK out a new drug target to reduce heart attacks

Researchers from Monash University’s Institute of Pharmaceutical Sciences (MIPS) together with other Monash and international collaborators have discovered a new target for drugs that could potentially prevent heart attacks and strokes by

MIPS researchers shine a light on the gap in national manufacturing capability of COVID vaccine

Monash University researchers have been featured in Australian media outlets as the global race to produce a vaccine against COVID-19 speeds up.

Nutrition breakthrough: Australian scientists mimic the behaviour of cow and human milk fats during digestion

In an important step forward for infant milk substitutes and nutrition, researchers from Monash University’s Institute of Pharmaceutical Sciences (MIPS) have shown that simple fat mixtures can imitate the behaviour of vastly more complex

Monash University study shows how potent antimalarial drug kills the malaria parasite

Researchers from Monash University’s Institute of Pharmaceutical Sciences (MIPS) have discovered that ozonide antimalarials – a new class of antimalarial drugs - initially target the precarious ‘haemoglobin digestion